查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
非阿片類疼痛療法市場規模、份額和趨勢分析報告：按藥物類別、疼痛類型、給藥途徑、分銷渠道、地區、市場預測2022-2030
市場調查報告書
商品編碼
1147578

非阿片類疼痛療法市場規模、份額和趨勢分析報告：按藥物類別、疼痛類型、給藥途徑、分銷渠道、地區、市場預測2022-2030

Non-opioid Pain Treatment Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, Acetaminophen, Local Anesthetics), By Pain Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

非阿片類疼痛治療市場的增長和趨勢

根據Grandview Research的最新報告，到2030年，全球非阿片類鎮痛藥物市場規模預計將達到779.1億美元，預測期內復合年增長率為8.3%。。這種增長歸因於炎症性疾病的日益流行和新型非阿片類鎮痛藥的強大產品線。根據疾病控制和預防中心 (CDC) 的數據，美國約有 3250 萬人患有骨關節炎，根據美國脊柱炎協會的數據，大約有 320 萬美國成年人患有某種形式的脊柱關節炎。據說有

為了滿足對止痛藥日益增長的需求，政府和非營利組織努力推廣使用更安全的阿片類藥物替代品，例如 NSAID。例如，2022 年 2 月，美國 FDA 發布指南草案，建議製藥公司開髮用於治療持續 30 天的急性疼痛的非甾體抗炎藥。這項工作是政府 HHS 過量預防戰略的一部分，該戰略側重於阿片類藥物過量患者的預防、減少、治療和康復。預計這些努力將在預測期內增加對非甾體抗炎藥的需求。

市場參與者正在積極開發創新技術，以滿足對用於疼痛管理的非甾體抗炎藥不斷增長的需求。例如，2021 年 6 月，亞利桑那大學開發了一種催產素類似物，用於治療患病患者。它是一種生物可利用的非阿片類鎮痛藥，可以通過吸入給藥。此類創新產品的開發有望推動非阿片類止痛藥治療市場的增長。

2022 年 9 月，由於胎兒出現腎臟問題的可能性增加，美國 FDA 建議在懷孕第 20 週期間避免使用非阿片類鎮痛藥。政府的此類舉措可能會限制非甾體抗炎藥的處方，從而抑制非阿片類鎮痛藥的市場增長。

公司正在採取新產品開發、發布和合作夥伴關係等戰略，以提高非阿片類止痛藥的滲透率。例如，2022 年 3 月，Vertex Pharmaceuticals 宣布了非阿片類藥物片劑在 2 期臨床試驗中的積極結果，該試驗顯著減輕了急性術後疼痛。成功的試驗和隨後的產品批准預計將在預測期內推動非阿片類藥物疼痛治療市場的增長。

由於競爭激烈的市場和大量參與者的存在，預計在預測期內市場競爭將加劇。生產仿製藥 NSAID 產品的主要公司包括 GSK plc.、Sun Pharmaceutical Industries Ltd.、Novartis AG、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Johnson & Johnson Services, Inc. 等公司。

非阿片類疼痛療法市場報告要點

到 2021 年，由於對疼痛治療的高需求以及近期多種非甾體抗炎藥的商業化，預計非甾體抗炎藥細分市場將佔據最大的市場份額並在預測期內保持主導地位

>

慢性疼痛將在 2021 年佔據最高份額。產品批准的增加、慢性疼痛的高發病率以及推出創新 NSAIDs 產品的高研發計劃等因素促成了這一優勢。

按給藥途徑類型劃分，由於口服非甾體抗炎藥產品易於給藥且在市場上廣泛供應，口服部分將在 2021 年佔據最高份額。

按分銷渠道劃分，零售藥店預計將在 2021 年以 53.98% 的份額主導市場。這種優勢可能是由於大量非甾體抗炎藥的存在，以及通過大型零售藥店網絡很容易接觸到患者

由於非甾體抗炎藥產品滲透率的提高、可支配收入的增加以及發展中國家炎症性疾病的高發率，預計亞太地區在預測期內將增長最快。

內容

第 1 章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 資訊採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
    • 初步調查的詳細資訊
  • 資訊或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
    • 商品流分析
      • 方法：產品流方法
  • 調查假設
  • 二級資訊列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望

第 3 章非阿片類疼痛療法市場變量、趨勢和範圍

  • 描繪滲透率和增長前景
  • 市場促進因素分析
    • 全球慢性和炎症性疾病的高發率
    • 增加產品批准和發布
    • 支持性監管和報銷政策
  • 市場抑制因素分析
    • 產品濫用
    • 與使用 Nsaid 相關的副作用
  • SWOT 分析，按因素（政治和法律、經濟、技術）
  • 行業分析 - 搬運工

第 4 章非阿片類藥物疼痛療法市場：細分分析，按藥物類別，2018-2030 年（百萬美元）

  • 定義和範圍
  • 非阿片類止痛藥市場：藥物類別的變化分析
  • 非甾體抗炎藥
  • 對乙□氨基酚
  • 局部麻醉劑
  • 其他

第 5 章非阿片類藥物疼痛治療市場：細分分析，按疼痛類型，2018-2030 年（百萬美元）

  • 定義和範圍
  • 非阿片類疼痛治療市場：疼痛類型的變化分析
  • 慢性疼痛
  • 術後疼痛
  • 癌痛
  • 其他

第 6 章。非阿片類藥物疼痛療法市場：細分分析，按給藥途徑，2018-2030 年（百萬美元）

  • 定義和範圍
  • 非阿片類止痛藥市場：給藥途徑變化分析
  • 口語
  • 主題
  • 可注射
  • 其他

第 7 章非阿片類藥物疼痛療法市場：細分分析，按分銷渠道，2018-2030 年（百萬美元）('000)

  • 非阿片類止痛藥市場：分銷渠道的變化分析
  • 醫院藥房
  • 零售藥房
  • 其他

第 8 章非阿片類藥物疼痛治療市場：細分分析，按地區劃分，2018-2030 年（百萬美元）

  • 市場份額分析
  • 2021 年和 2030 年區域市場份額分析
  • 區域市場概況
  • 2021-2030 年市場規模、預測、收入和趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多邊環境協定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 9 章非阿片類疼痛治療市場：競爭分析

  • 主要市場進入者的近期趨勢和影響分析
    • 新產品發布
    • 併購
    • 夥伴關係和戰略協作
    • 會議和活動
  • 公司分類
    • 創新者
    • 市場領導者
    • 熱圖分析
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
  • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 公司市場分析
    • 公司市場分析
    • 競爭儀表板分析
      • 市場差異化因素
  • 私人公司
    • 主要初創企業名單
    • 本地網絡地圖
  • 公司簡介
    • NOVARTIS AG
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • DR. REDDY'S LABORATORIES LTD
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • SUN PHARMACEUTICAL INDUSTRIES LTD
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • GSK PLC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • PFIZER INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • PERRIGO COMPANY PLC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • LNK INTERNATIONAL, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CIPLA INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • JOHNSON &JOHNSON SERVICES, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • PACIRA PHARMACEUTICALS, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • PIERREL
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-983-1

Non-opioid Pain Treatment Market Growth & Trends:

The global non-opioid pain treatment market size is expected to reach USD 77.91 billion by 2030, registering a CAGR of 8.3% during the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to an increase in the prevalence of inflammatory diseases coupled with the robust product pipeline of novel non-opioid analgesics. According to the Centers for Disease Control and Prevention (CDC), around 32.5 million people are living with osteoarthritis condition in the U.S. In addition, according to the Spondylitis Association of America, about 3.2 million adult people in the U.S. have some form of Spondyloarthritis.

Initiatives are undertaken by government & nonprofit organizations to promote the usage of safer alternatives to opioids such as NSAIDs to address the increasing demand for pain relieving medicines. For instance, in February 2022, the U.S.FDA issued draft guidelines to provide recommendations to pharmaceutical companies for developing NSAIDs for the treatment of acute pain lasting for 30 days. This initiative was a part of the government's "HHS Overdose Prevention Strategy" which focuses on the prevention, reduction, treatment, and recovery of patients from an opioid overdose. Such an initiative is projected to fuel demand for NSAID drugs over the forecast period.

Key market players are aggressively developing innovative techniques to meet the growing demand for NSAIDs for the management of pain. For instance, in June 2021, the University of Arizona developed oxytocin analogs for the treatment of patients suffering from. It is a bioavailable non-opioid pain relief product with the potential for inhaled administration. The development of such an innovative product is anticipated to drive non-opioid analgesics treatment market growth.

In September 2022, the U.S. FDA recommended avoiding non-opioid analgesics treatment in pregnancy at 20 weeks due to the high chances of kidney problems in unborn babies. Such initiatives from governments may limit the prescription of NSAIDs, thereby, restraining non-opioid pain treatment market growth.

Companies are adopting strategies such as new product development, launches, and partnerships to increase the penetration of non-opioid analgesic products. For instance, in March 2022, Vertex Pharmaceuticals announced positive results of its phase 2 clinical trial non-opioid pill that showed a significant reduction in post-operative acute pain. Successful completion of trial and subsequent approval of products is anticipated to drive non-opioid analgesics treatment market growth during the forecast period.

The market is highly competitive and the competition in the market is expected to be high during the forecast period due to the presence of a large number of players. Key companies manufacturing generic NSAID products include GSK plc., Sun Pharmaceutical Industries Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Johnson & Johnson Services, Inc., amongst others.

Non-opioid Pain Treatment Market Report Highlights:

  • In 2021, the NSAIDs segment accounted for the largest market share and is anticipated to maintain its dominance over the forecast period owing to the high demand for pain treatment and the commercialization of multiple NSAIDs in recent years
  • Chronic pain was the accounted for highest share in 2021. Factors such as increasing product approvals, the high incidence rate of chronic pain, and high R&D initiatives for launching innovative NSAIDs products are leading to its dominance
  • Based on route of administration type, the oral segment accounted for the highest share in 2021 owing to the easy administration and wide availability of orally administered NSAIDs products in the market
  • Based on the distribution channel, retail pharmacies are expected to dominate the market with a 53.98% share in 2021. This dominance can be attributed to the presence of a large number of generic NSAIDs and their easy accessibility to patients due to the large presence of retail pharmacies network
  • Asia Pacific region is expected to experience the fastest growth during the forecast period owing to an increase in penetration of NSAIDs products, rise in disposable income, and high disease prevalence of inflammatory diseases in developing countries

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Non-Opioid Pain Treatment Market Variables, Trends, and Scope

  • 3.1 Penetration and Growth Prospect Mapping
  • 3.2 Market Driver Analysis
    • 3.2.1 High Prevalence Of Chronic & Inflammatory Diseases Globally
    • 3.2.2 Increasing Product Approvals And Launches
    • 3.2.3 Supportive Regulatory And Reimbursement Policies
  • 3.3 Market Restraint Analysis
    • 3.3.1 Misuse Of Product
    • 3.3.2 Side-Effects Associated With Use Of Nsaids
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • 3.5 Industry Analysis - Porter's

Chapter 4 Non-Opioid Pain Treatment Market: Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)

  • 4.1 Definitions and Scope
  • 4.2 Non-Opioid Pain Treatment Market: Drug Class Movement Analysis
  • 4.3 NSAIDs
    • 4.3.1 Nsaids Market, 2018 - 2030 (USD Million)
    • 4.3.2 Selective Cox-2 Inhibitors Market, 2018 - 2030 (USD Million)
      • 4.3.2.1 Nsaids Market, 2018 - 2030 (USD Million)
    • 4.3.3 Non-Selective Nsaidsmarket, 2018 - 2030 (USD Million)
      • 4.3.3.1 Nsaids Market, 2018 - 2030 (USD Million)
  • 4.4 Acetaminophen
    • 4.4.1 Acetaminophen Market, 2018 - 2030 (USD Million)
  • 4.5 Local Anesthetics
    • 4.5.1 Local Anesthetics Market, 2018 - 2030 (USD Million)
  • 4.6 Others
    • 4.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Non-Opioid Pain Treatment Market: Segment Analysis, by Pain Type, 2018 - 2030 (USD Million)

  • 5.1 Definitions & Scope
  • 5.2 Non-Opioid Pain Treatment Market: Pain Type Movement Analysis
  • 5.3 Chronic Pain
    • 5.3.1 Chronic Market, 2018 - 2030 (USD Million)
    • 5.3.2 Neuropathic Pain Market, 2018 - 2030 (USD Million)
      • 5.3.2.1 Neuropathic Pain Market, 2018 - 2030 (USD Million)
    • 5.3.3 Inflammatory Conditions Market, 2018 - 2030 (USD Million)
      • 5.3.3.1 Neuropathic Pain Market, 2018 - 2030 (USD Million)
  • 5.4 Post-Operative Pain
    • 5.4.1 Post-Operative Pain Market, 2018 - 2030 (USD Million)
  • 5.5 Cancer Pain
    • 5.5.1 Cancer Pain Market, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Non-Opioid Pain Treatment Market: Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)

  • 6.1 Definitions and Scope
  • 6.2 Non-Opioid Pain Treatment Market: Route of Administration Movement Analysis
  • 6.3 Oral
    • 6.3.1 Oral Market, 2018 - 2030 (USD Million)
  • 6.4 Topical
    • 6.4.1 Topical Market, 2018 - 2030 (USD Million)
  • 6.5 Injectable
    • 6.5.1 Injectable Market, 2018 - 2030 (USD Million)
  • 6.6 Others
    • 6.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Non-Opioid Pain Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million) ('000)

  • 7.1 Non-Opioid Pain Treatment Market: Distribution Channel Movement Analysis
  • 7.2 Hospital Pharmacy
    • 7.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 7.3 Retail Pharmacy
    • 7.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 7.4 Others
    • 7.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Non-Opioid Pain Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Market Share Analysis
  • 8.2 Regional Market Share Analysis, 2021 & 2030
  • 8.3 Regional Market Snapshot
  • 8.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
    • 8.4.1 North America
      • 8.4.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.4.1.2 U.S.
      • 8.4.1.2.1 U.S. Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.1.3 Canada
      • 8.4.1.3.1 Canada Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
    • 8.4.2 Europe
      • 8.4.2.1 Europe Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.2.2 U.K.
      • 8.4.2.2.1 U.K. Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.2.3 Germany
      • 8.4.2.3.1 Germany Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.2.4 Spain
      • 8.4.2.4.1 Spain Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.2.5 France
      • 8.4.2.5.1 France Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.2.6 Italy
      • 8.4.2.6.1 Italy Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
    • 8.4.3 Asia Pacific
      • 8.4.3.1 Asia Pacific Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.3.2 Japan
      • 8.4.3.2.1 Japan Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.3.3 China
      • 8.4.3.3.1 China Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.3.4 India
      • 8.4.3.4.1 India Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.3.5 South Korea
      • 8.4.3.5.1 South Korea Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.3.6 Australia
      • 8.4.3.6.1 Australia Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
    • 8.4.4 Latin America
      • 8.4.4.1 Latin America Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.4.2 Brazil
      • 8.4.4.2.1 Brazil Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.4.3 Mexico
      • 8.4.4.3.1 Mexico Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.4.4 Argentina
      • 8.4.4.4.1 Argentina Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
    • 8.4.5 MEA
      • 8.4.5.1 MEA Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.5.2 South Africa
      • 8.4.5.2.1 South Africa Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.5.3 Saudi Arabia
      • 8.4.5.3.1 Saudi Arabia Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)
      • 8.4.5.4 UAE
      • 8.4.5.4.1 UAE Non-Opioid Pain Treatment Market, 2018 - 2030 (USD Million)

Chapter 9 Non-Opioid Pain Treatment Market: Competitive Analysis

  • 9.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 9.1.1 New Product Launches
    • 9.1.2 Mergers And Acquisitions
    • 9.1.3 Partnerships And Strategic Collaboration
    • 9.1.4 Conferences And Campaigns
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
    • 9.2.3 Heat Map Analysis
  • 9.3 Vendor Landscape
    • 9.3.1 List Of Key Distributors And Channel Partners
    • 9.3.2 Key Customers
  • 9.4 Key Company Market Share Analysis, 2021
  • 9.5 Public Companies
    • 9.5.1 Company Market Position Analysis
    • 9.5.2 Company Market Position Analysis
    • 9.5.3 Competitive Dashboard Analysis
      • 9.5.3.1 Market Differentiators
  • 9.6 Private Companies
    • 9.6.1 List Of Key Emerging Companies
    • 9.6.2 Regional Network Map
  • 9.7 Company Profiles
    • 9.7.1 NOVARTIS AG
      • 9.7.1.1 Company overview
      • 9.7.1.2 Financial performance
      • 9.7.1.3 Product benchmarking
      • 9.7.1.4 Strategic initiatives
    • 9.7.2 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
      • 9.7.2.1 Company overview
      • 9.7.2.2 Financial performance
      • 9.7.2.3 Product benchmarking
      • 9.7.2.4 Strategic initiatives
    • 9.7.3 DR. REDDY'S LABORATORIES LTD
      • 9.7.3.1 Company overview
      • 9.7.3.2 Financial performance
      • 9.7.3.3 Product benchmarking
      • 9.7.3.4 Strategic initiatives
    • 9.7.4 SUN PHARMACEUTICAL INDUSTRIES LTD
      • 9.7.4.1 Company overview
      • 9.7.4.2 Financial performance
      • 9.7.4.3 Product benchmarking
      • 9.7.4.4 Strategic initiatives
    • 9.7.5 GSK PLC.
      • 9.7.5.1 Company overview
      • 9.7.5.2 Financial performance
      • 9.7.5.3 Product benchmarking
      • 9.7.5.4 Strategic initiatives
    • 9.7.6 PFIZER INC.
      • 9.7.6.1 Company overview
      • 9.7.6.2 Financial performance
      • 9.7.6.3 Product benchmarking
      • 9.7.6.4 Strategic initiatives
    • 9.7.7 PERRIGO COMPANY PLC.
      • 9.7.7.1 Company overview
      • 9.7.7.2 Financial performance
      • 9.7.7.3 Product benchmarking
      • 9.7.7.4 Strategic initiatives
    • 9.7.8 LNK INTERNATIONAL, INC.
      • 9.7.8.1 Company Overview
      • 9.7.8.2 Financial Performance
      • 9.7.8.3 Product Benchmarking
      • 9.7.8.4 Strategic Initiatives
    • 9.7.9 CIPLA INC.
      • 9.7.9.1 Company Overview
      • 9.7.9.2 Financial Performance
      • 9.7.9.3 Product Benchmarking
      • 9.7.9.4 Strategic Initiatives
    • 9.7.10 JOHNSON & JOHNSON SERVICES, INC.
      • 9.7.10.1 Company Overview
      • 9.7.10.2 Financial Performance
      • 9.7.10.3 Product Benchmarking
      • 9.7.10.4 Strategic Initiatives
    • 9.7.11 PACIRA PHARMACEUTICALS, INC.
      • 9.7.11.1 Company Overview
      • 9.7.11.2 Financial Performance
      • 9.7.11.3 Product Benchmarking
      • 9.7.11.4 Strategic Initiatives
    • 9.7.12 PIERREL
      • 9.7.12.1 Company Overview
      • 9.7.12.2 Financial Performance
      • 9.7.12.3 Product Benchmarking
      • 9.7.12.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 List of key distributors
  • Table 4 List of other companies
  • Table 5 List of key emerging company's/technology disruptors/innovators
  • Table 6 North America Non-Opioid Pain Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 9 North America Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 10 North America Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 U.S. Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 Canada Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 16 Canada Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Canada Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Non-Opioid Pain Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Europe Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 23 Europe Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 U.K. Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 U.K. Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 26 U.K. Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 U.K. Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Germany Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 29 Germany Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 30 Germany Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 Germany Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 France Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33 France Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 34 France Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 35 France Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Spain Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Spain Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 38 Spain Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 Spain Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Italy Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Italy Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 42 Italy Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Italy Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Japan Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Japan Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 50 Japan Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 51 Japan Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 China Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 53 China Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 54 China Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 55 China Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 India Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 57 India Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 58 India Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 India Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 Australia Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 61 Australia Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Australia Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 South Korea Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 65 South Korea Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 South Korea Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 Latin America Non-Opioid Pain Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 Latin America Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Brazil Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 74 Brazil Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 76 Brazil Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Mexico Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 78 Mexico Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 79 Mexico Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 Mexico Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 81 Argentina Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 82 Argentina Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 83 Argentina Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 84 Argentina Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 MEA Non-Opioid Pain Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 86 MEA Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 87 MEA Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 88 MEA Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 89 MEA Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 South Africa Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 91 South Africa Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 92 South Africa Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 93 South Africa Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 97 Saudi Arabia Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 98 UAE Non-Opioid Pain Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 90 UAE Non-Opioid Pain Treatment Market, By Pain Type, 2018 - 2030 (USD Million)
  • Table 100 UAE Non-Opioid Pain Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 101 UAE Non-Opioid Pain Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Non-opioid analgesics treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2021)
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 Non-Opioid pain treatment market driver impact
  • Fig. 12 Non-Opioid pain treatment market restraint impact
  • Fig. 13 Non-Opioid pain treatment market opportunity impact
  • Fig. 14 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 15 Porter's Five Forces Analysis
  • Fig. 16 Non-Opioid pain treatment drug class outlook: Key takeaways
  • Fig. 17 Non-Opioid pain treatment market: Drug class movement analysis (USD Million)
  • Fig. 18 NSAIDs market, 2018 - 2030 (USD Million)
  • Fig. 19 Acetaminophen market, 2018 - 2030 (USD Million)
  • Fig. 20 Local Anesthetics market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Non-Opioid pain treatment pain type outlook: Key takeaways
  • Fig. 23 Non-Opioid pain treatment market: Pain type movement analysis (USD Million)
  • Fig. 24 Chronic pain market, 2018 - 2030 (USD Million)
  • Fig. 25 Post-operative pain market, 2018 - 2030 (USD Million)
  • Fig. 26 Cancer pain market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Non-Opioid route of administration outlook: Key takeaways
  • Fig. 29 Non-Opioid pain treatment market: Route of administration movement analysis (USD Million)
  • Fig. 30 Oral market, 2018 - 2030 (USD Million)
  • Fig. 31 Topical market, 2018 - 2030 (USD Million)
  • Fig. 32 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2018 - 2030 (USD Million)
  • Fig. 34 Non-Opioid pain treatment distribution channel outlook: Key takeaways
  • Fig. 35 Non-Opioid pain treatment market: Distribution channel movement analysis (USD Million)
  • Fig. 36 Hospital Pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 37 Retail Pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 38 Other market, 2018 - 2030 (USD Million)
  • Fig. 39 Regional outlook, 2021 & 2030
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 North America
  • Fig. 42 North America non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe
  • Fig. 48 Europe non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 49 U.K.
  • Fig. 50 U.K. non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 51 Germany
  • Fig. 52 Germany non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain
  • Fig. 54 Spain non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 France
  • Fig. 56 France non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 Italy
  • Fig. 58 Italy non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific
  • Fig. 60 Asia Pacific non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 Japan
  • Fig. 62 Japan non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 China
  • Fig. 64 China non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 India
  • Fig. 66 India non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea
  • Fig. 68 South Korea non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 69 Australia
  • Fig. 70 Australia non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America
  • Fig. 72 Latin America non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil
  • Fig. 74 Brazil non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 75 Mexico
  • Fig. 76 Mexico non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina
  • Fig. 78 Argentina non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 79 Middle East and Africa
  • Fig. 80 MEA non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 81 South Africa
  • Fig. 82 South Africa non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 83 Saudi Arabia
  • Fig. 84 Saudi Arabia non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 85 UAE
  • Fig. 86 UAE non-opioid pain treatment market, 2018 - 2030 (USD Million)
  • Fig. 87 Heat map analysis
  • Fig. 88 Company market position analysis (2021)
  • Fig. 89 Company market position analysis (2021)
  • Fig. 90 Company market position analysis (2021)
  • Fig. 91 Market differentiators
  • Fig. 92 Regional Network Map